Elevance Health, Inc. Hits New 52-Week High of USD 426.53

Elevance Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 426.53 on June 9, 2026. This achievement highlights the company's performance within the healthcare services industry, where it operates as a large-cap entity with a market capitalization of USD 63,208 million. Despite the recent uptick in stock price, Elevance Health's one-year performance reflects a decline of 20.85%, contrasting sharply with the S&P 500's gain of 22.99% over the same period. The company's price-to-earnings (P/E) ratio stands at 11.00, indicating its valuation relative to earnings, while its dividend yield is reported at 2.46%. Additionally, Elevance Health maintains a debt-to-equity ratio of -0.09, suggesting a strong balance sheet, and a return on equity of 12.90%, which demonstrates effective management of shareholder equity. The stock's 52-week low was recorded at USD 273.71, marking a notable recovery to its current high. This performance underscores the dynamic nature of Elevance Health's market position within the healthcare sector.